|
December,
1999
headlines and summaries
Return
to December article index
Biotech
beer turns off brewing industry
December
28
AP
BISMARCK, N.D. - Charles Ottem would love to see the barley in his
fields be immune to disease, but brewing companies worry that beer
drinkers might be turned off if genetic engineering made that possible.
``It's something we can't shove down people's throats. We all have to
get better at communicating and compromising,'' said Rick Ward, a wheat
breeder at Michigan State University. ``The consumer is king, and they
will rule no matter what.''
In North Dakota, which leads the nation in barley production, this
year's crop was the smallest in more than a decade. A fungal disease
called scab has cost farmers in the Northern Plains an estimated $2.6
billion in lost crops from 1991 through 1997 alone.
``Scab, for all practical purposes, has devastated the barley industry
in this state,'' said Ottem, a North Dakota farmer and chairman of the
state's Barley Council. ``That's the only way we're going to find the
solution to all of our disease problems - manipulating genes.''
Barley is used to make beer, but scab-infested barley can affect the
taste and cause the beer to gush out of the bottle.
Genetic engineering involves manipulating the genes of a plant. With
the growing controversy over biotech food, some overseas brewers already
are refusing to buy grain genetically designed to kill pests or withstand
herbicides or disease.
In the United States, the brewing industry is still pinning its hopes
on a more conventional solution to scab.
``The majority of (research) funds being expended are for traditional
breeding programs,'' said Mike Davis, president of the American Malting
Barley Association, a trade group for major malting and brewing companies.
``Our general thoughts are that (biotech) research should be pursued as a
possible avenue to solve the scab problem.''
At the U.S. Department of Agriculture's Agricultural Research Service
facility in Madison, Wis., molecular biologist Ronald Skadsen is trying to
create a barley that has antifungal genes in the right place to ward off
the scab fungus.
At the ARS facility in Fargo, N.D., geneticist Lynn Dahleen is trying
to insert genes into barley that will reduce the toxins caused by scab.
Both say a biotech solution to scab could be as much as a decade away.
``This particular disease has been a bigger challenge than most,''
Dahleen said. ``We don't have a single gene we can breed in that will give
resistance.''
Ward, the wheat breeder, said it's too early to tell whether the
efforts of Dahleen, Skadsen and others will produce a barley immune to
scab.
``We would be remiss to ignore the opportunity to interrogate these
complex systems with these very eloquent approaches,'' he said.
Brewers have come to rely more on barley from Canada and the western
United States, Davis said. But even if a biotech solution to scab could be
found, brewers probably would not rush to embrace it, he said.
``If one was commercially developed, at that time it would have to be
thoroughly tested, and a decision made as to whether it could be used,''
he said. ``For any companies selling a food product, they always weigh
market considerations.''
Canadian
food producers in disarray
December
27
National Post
The battle over genetically modified food has crossed
the Atlantic.
Any doubt about that was put to rest last week after
Tesco Stores Ltd., Britain's largest supermarket chain, warned suppliers
of meat and dairy products, including some Canadian firms, not to use
genetically modified grain in their animal feed. While that hardly amounts
to a consumer revolt against "frankenfood," it is a shot across
the bows for Canadian food producers.
Alarmingly, the industry appears to have been taken by
surprise and is in disarray as to how to handle the issue.
Chris Kyte, president of the Food Institute of Canada,
an association representing 150 food processing companies, said,
"From where I sit, I don't see a big consumer concern over GM foods.
I've had five letters, all written by special interest groups, and I am
not aware of any company that has gotten more than 10 letters. I think
consumers are very comfortable with the [Canadian] food inspection system
and food they eat."
As far as the controversy in Europe, Mr. Kyte said,
"Let's face it. It's a great trade barrier for the Europeans."
In any case, he argues, Europe is a small market for
Canadian food producers. If it falls off the map, Canada wouldn't notice.
On the opposite side of the spectrum is the Canadian
Wheat Board, which is getting set to face what it believes is the
inevitable. In a speech last October, Greg Arason, the chief executive of
the board, made it clear that it is time for the agricultural sector to
start looking at ways to segregate GM crops. "Whether or not the
customer has an incorrect or incomplete scientific knowledge, if they
think there will be a negative public reaction to a certain product, they
simply will not buy it. This is a bottom line that must be
recognized."
But Mr. Arason is in the minority.
Many of those contacted for this story refused requests
for interviews, referring questions to industry associations (such as Mr.
Kyte's) charged with stick handling the issue.
One approach that seems to be gaining momentum is a
voluntary labeling system, which, if implemented, would allow
manufacturers to identify GM components in their products, in the same way
that manufacturers list nutritional components.
The idea, according to Jeanne Cruikshank, regional
vice-president of the Canadian Council of Grocery Distributors, is to
provide a set of consistent rules so food manufacturers, if they choose,
can label their products to identify genetic components.
Coming up with a set of guidelines that makes sense is a
difficult problem, she says. First you have to decide what it means to say
something has been genetically modified. How much of a GM ingredient
do you need in a product before you have to refer to it on a label?
And how far down the food chain do you go? Is it significant if beef used
in a hamburger was fed GM grain? And so forth.
But will giving manufacturers the option of identifying
GM ingredients in their products put consumers at their ease? Experience
in just about every other industrialized country seems to suggest that the
food industry is in for a rude awakening.
In Japan, the Kirin and Sapporo breweries have stopped
using transgenic maize in their beer and the national tofu manufacturers'
association has opted to use only non-genetically modified soy beans in
its tofu production.
In Mexico, at least one taco manufacturer, Groupo Maseca,
has announced plans to use only non-GM flour.
Closer to home, McCain Foods, one of the world's largest
makers of french fries, has been quietly informing potato growers that it
will not accept transgenetic varieties.
The coupe de grace came earlier this month as Monsanto
Co., one of the world's leading developers of transgenic crops, announced
plans to spin off part of its prized crop development business.
Analysts saw the development as a strategic U-turn for Monsanto,
which had previously described the business as the foundation upon which
it would build its future success.
Now it seems the retreat is turning into a rout. In a
remarkable disclosure, Monsanto revealed last week that GM food has been
banned from the cafeteria at its head office in Britain.
"We believe in choice," Tony Combes, the
company's director of corporate affairs, is reported to have said. He
denied it was an embarrassment for the company.
So far, only a handful of crops grown in this country
has been genetically modified, mostly varieties of soya, canola and corn.
Very soon there will be a lot more. The bottom line is that the cost of
establishing dual production systems would be hugely expensive, say
observers. The end result would be dramatic increases in food prices.
Soy sauce is not
just soy sauce, it seems
December 27
Dow Jones
NARUTO, Japan -- At his family's tiny factory in the
heart of Japanese soy-sauce country, Mamoru Otaka has brewed up trouble.
Bottles of his soy sauce are sporting a garish green
sticker these days. "NonGMO," it declares -- that is, free of
genetically modified organisms. And though Mr. Otaka has labeled only a
small part of his output this way, he is roiling the soy-sauce business,
stating, "We're throwing a stone into calm water."
Soy sauce is one of the oldest products in Japan, an
integral part of its cuisine since the 13th century. Now this ancient
industry is grappling with the most modern of controversies:
gene-splicing, which has led authorities to order labeling for 29
categories of foods if they have any bioengineered ingredients.
The soy-sauce world thought it would dodge this. The
government exempted soy sauce from labeling, because experts concluded it
was impossible to tell whether the sauce contained genetically modified
ingredients. That is because the fermentation process by which soy sauce
is made -- out of soybeans, wheat, salt and water -- breaks up the
soybeans' DNA.
But suppose somebody labels his soy sauce anyway,
calling it GMO-free? Small soy-sauce producers here have a tough go of it.
Thousands have folded in the past 50 years, and a few giants now dominate
the $2.1 billion business. In search of a competitive edge, or just a way
to survive, a few small producers have decided to play the genetics
card.
This greatly troubles the soy-sauce establishment.
Tetsuya Konagai, director of the Japan Soy Sauce Association said,
"Consumers' level of trust is very high with soy sauce. We don't want
to lose that over something like this." The group is urging brewers
to hold off on labeling while it tries to come up with rules.
No one is more establishment than Kikkoman Corp.,
Japan's biggest soy-sauce brewer. Kikkoman advocates acting as Japanese
industries often strive to do at times of disturbing change: in harmony.
Even though Kikkoman has a line of organic soy sauce that would qualify as
non-GM, it has made a point of refraining from such labeling. To
renegades like Mr. Otaka, "we're telling them that it's better to
follow" the group, says Yuzaburo Mogi, the president of Kikkoman,
which traces its origins to a business set up by the widow of a samurai
around 1630.
Mr. Otaka's firm has some history itself. Otaka Shoyu
Co. was founded by his great-great-great-grandfather, Shoemon Otaka, in
1804. Much of the time since then, the company, with less than $6 million
in annual sales, has struggled in the shadow of mighty rivals. Its brewery
is in the middle of Chiba Prefecture, east of Tokyo, where it is
surrounded by major soy-sauce companies, including the original piece of
Kikkoman.
He knows he can't compete with the likes of Kikkoman,
which use high-tech machines to control fermentation and, he says, have
soy sauce "down to perfection." But when the restaurant clients
started calling to ask if Otaka Shoyu's soybeans were genetically
modified, Mamoru had a revelation: If he could prove they weren't, there
was a market waiting.
In any case, he was annoyed that suppliers had shifted
to supplying genetically modified beans without telling him, and that the
sauce industry was pressuring everyone to keep mum. "There's a
perception out there that you're supposed to keep quiet," he says.
"If it serves as advertising, you should be able to advertise
it."
Sitting in a cramped conference room with a little altar
to the Shinto god of soy sauce, and dressed in a purple warm-up suit,
Mamoru explains how he started with his line of organic sauce. He asked
the Japanese branch of an Iowa gene-testing company to inspect his organic
soybeans to make sure they weren't bioengineered. Then the testing company
examined the entire manufacturing process for potential
"contamination" with bioengineered beans. It provided a stack of
bright-green "Non-GMO" stickers, which Mamoru slapped on bottles
of organic soy sauce. He packaged them with other condiments in boxed sets
for Japan's winter gift-giving season and sent them off to department
stores, where they are selling well.
He also changed soybean suppliers for the soy sauce
Otaka Shoyu sells to restaurants, switching to U.S. beans that aren't
grown from gene-spliced seed but cost 50 percent more. He plans to leave
prices unchanged, figuring no one wants to pay more for soy sauce.
That strategy puts pressure on other small producers.
"I wish they wouldn't do such a needless thing," grumbles
Hansuke Takahashi, president of Fujihan Shoyu KK. "If someone starts
labeling, then we may all have to label, and that raises the price. But
soy sauce isn't the kind of thing you could sell at a higher price."
Another tiny rival is unhappy with Mamoru's move for a
different reason. Kondo Jozomoto already uses non-GM soybeans, grown
locally, and markets high-end sauces. But it fears that a non-GM trend
would bid up the cost of its raw materials.
Japan's brewers rely mostly on lowcost, protein-rich
soybeans from America, known here as IOM -- for Indiana, Ohio and
Michigan.
More and more of those are genetically modified. In
1999, U.S. farmers planted about half of their soybean acreage with seeds
altered so the plants could stand being sprayed by a potent weedkiller.
That has stirred the ire of environmentalists, some of whom contend one
can't be sure the beans are safe to eat.
Thanks to their campaign, Japanese consumer groups are
calling for labeling on all soy sauce. One big supermarket chain has
recently started labeling for GM ingredients in its store brand.
Restaurants are exempt from labeling, but some have begun touting non-GM
dishes.
And so, quietly, some small brewers are preparing for a
possible soybean war. A brewer called Taihei Co. is producing a non-GM
sauce at the request of a Tokyo food cooperative and has displayed its
sauce at a trade fair with a discreet non-GM sign. That's as far as it
dares go for now. It hasn't pasted on labels, whispers a plant manager,
because "there may be pressure" from the soy-sauce association
not to.
In Naruto, Mamoru Otaka points to a thick, dark liquid
bubbling away in a 30,000-liter steel tank. It's the first batch of soy
sauce made from his new non-GM soybeans, he says excitedly. Inquiries are
coming in, such as from trading companies proposing to sell his soy sauce
in the United Kingdom.
As for playing the genetics card, he has no regrets.
"We've been preserving a traditional industry in Japan," he
says. "It's the Otaka way to keep making soy sauce the way it always
was."
Texas
farmers divided over genetically modified crops
Growers
consider consumer perception of biotech foods before cutting back
December
25
Dallas Morning News
Texas farmers are closely watching the widening debate over genetically
modified crops. But most aren't cutting back just yet on planting the
biotech strains of corn, cotton and soybeans that help reduce their costs
of fighting weeds and pests.
Opposition largely has come from the European Union, where activist
groups, retailers and consumers want mandatory labeling of foods
containing genetically engineered products. Activist organizations
operating in Europe have vowed to make it an issue here as well, although
the U.S. government has not determined that biotech foods are harmful.
Already, some manufacturers such as baby-food makers Gerber and Heinz
have said they would try to keep their products free of genetically
modified ingredients. And Archer Daniels Midland Co., an international
food-processing conglomerate, has instructed suppliers in the Midwest to
segregate biotech grain from that grown conventionally.
That, in turn, has raised anxiety among farmers, mainly in the Midwest,
where much of the crops are exported to Europe and elsewhere. Worried that
their crops would have nowhere to go, some have decided to cut back on
genetically modified seed purchases.
The situation is different in Texas, where most grain is grown for feed
rather than for food or export. And no grain elevators have reported that
they are segregating grain. Still, some farmers are wary.
"I'll do whatever is necessary to make our product agreeable to
the consumer," said Harlan Huffman, who farms with his wife, Hope,
and son, Kevin, near McGregor in Central Texas. "In some cases,
perception is reality. I'm very concerned about what our customers want
and say."
The stakes are high both for farmers and biotech companies. More than
half of the corn, soybeans and cotton grown in Texas is genetically
altered. And companies such as Monsanto Co. and DuPont Co. have spent
hundreds of millions of dollars to develop seeds with traits that protect
plants from pests, herbicides and pesticides.
In Texas, the most common biotech crop products are "Roundup
Ready" for cotton, corn and soybeans, which guards crops against the
powerful herbicide Roundup; and various forms of so-called "Bt"
cotton and corn. The latter stands for Bacillus thuringiensis, a bacterium
and natural pesticide.
Bt cotton has a built-in resistance to pests such as bollworms and
budworms. Bt corn hybrids protect against corn borers. Both reduce the
need to spray chemicals to kill the insects, making crop production more
environmentally friendly, proponents say.
Kevin Huffman, who's taking over his parents' crop operation, plants
Roundup Ready corn and soybeans and has no plans to cut back. He can spray
Roundup on top of the crop without hurting it, alleviating the need to
spot-spray or hoe weeds.
On soybeans, he saves about $5 an acre in herbicide costs. Spread
across the state's 400,000 acres of soybeans, that's a potential annual
savings of around $2 million.
"My belief is that it is completely safe," he said.
"When I look at genetically modified crops, I'm looking at dollars
and cents, and what I'm going to gain from it."
While the biotech crops have not been proved harmful, there are plenty
of concerns.
Some observers worry that insects could build up a resistance to
bio-engineered crops, and some scientists believe that the genetic process
could have the unintended effect of boosting natural toxins or reducing
nutrients in some foods. Others fear that some people could be allergic to
certain proteins introduced into biotech foods.
Several years ago, soybeans altered with a gene from a Brazil nut
caused a reaction in individuals who were allergic to Brazil nuts - and
therefore were never marketed.
Earlier this year, researchers at Cornell University determined that
pollen from Bt corn can kill monarch butterflies, a cousin of the corn
borer. Greenpeace activists seized on the study and demonstrated against
Bt corn in Europe - wearing butterfly costumes.
"I think all of our farmers are becoming concerned about the
attention the issue is getting, and whether or not they are going to be
able to market their crop once it's grown," said Gene Hall, a
spokesman for the Texas Farm Bureau, the state's largest farm
organization.
Agriculture Secretary Dan Glickman announced a program in July designed
to shore up public and farmer confidence in the technology, while also
providing for independent scientific review. But he's acknowledged that if
American consumers ultimately want their foods labeled, they're entitled
to it.
"I think there is concern among producers that the dialog is more
fear-based than science-based," said Steve Verett, executive vice
president of Plains Cotton Growers Association in Lubbock. "The level
of concern is much higher now than it was six months ago."
Most of the cotton grown on the West Texas high plains is modified
Roundup Ready, and Mr. Verett doesn't expect any significant reduction in
2000.
However, he thinks the issue is making producers "assess the need
for it."
In a Monsanto survey of about 100 Texas cotton producers who have used
biotech seed, 97 percent said they intended to replant Roundup Ready, and
94 percent would once again go with Bt cotton, says Doug Dorsey, the
company's south region marketing manager.
"We're pleased with what we've sold to date," he said, adding
that it's too early to tell what producers actually will do at spring
planting.
Another survey, this one of grain elevators across the South, showed
that only a handful of elevators bothered to segregate genetically
modified corn and soybeans this past harvest, or to even ask farmers if
they used the technology, Mr. Dorsey says.
Wayne Martin, president of PYCO Industries, which operates a cottonseed
mill in Lubbock that produces cooking oil, says it would be impossible to
segregate cottonseed produced from Roundup Ready plants.
The decision by Archer Daniels Midland to ask elevators to separate
biotech grain "kind of puts up a red flag" to producers, says
Hill County agricultural extension agent Bill Buxkemper. He says some seed
dealers in his area are booking fewer Roundup Ready soybean seed sales for
the coming year, and says there also may be some reduction in biotech
cotton and corn seed sales.
The situation is less clear in the prime corn-growing region of the
Texas Panhandle.
"There's a lot of confusion out there right now," said Jim
Schrib, in the Amarillo office of seed company Pioneer Hi-Bred
International, part of DuPont. "It doesn't appear right now that they
[farmers] are coming out of genetically modified crops."
Texas grain elevators would be hard-pressed to keep biotech grain
separate. For one thing, there's apparently no reliable test to show
whether a crop has been genetically modified. Elevators would have to take
the farmer's word for it. And even if a farmer plants nonbiotech crops,
they could be dusted by pollen drifting over from a neighbor's farm that
genetically modifies crops.
"We're not going to segregate until we find a way to test for
it," said Joe Mueck, general manager of Williamson County Grain in
Taylor. He says he's been checking the Internet for companies that are
developing testing. "Down the line, we might [segregate] if enough
people ask for it."
Some experts believe that it may not get to that point in Texas. Much
of the grain that isn't grown for feed is exported to non-European
countries, such as Mexico, says Dr. Cloyce Coffman, a Texas Agricultural
Extension Service agronomist.
But there's this potential wrinkle: Some biotech opponents are
beginning to raise objections to cattle being fed with genetically
modified corn feed.
"If it turns out that beef is boycotted," Dr. Coffman said,
"that could be a different ballgame."
Monsanto's Shapiro
seen as laid-back visionary
December
20
Reuters
As head of Monsanto Co., the life sciences firm which
agreed on Sunday to merge with drug group Pharmacia & Upjohn Inc.,
Robert Shapiro has earned the reputation as a laid-back manager who
encourages co-workers to call him "Bob."
Shapiro, 61, prefers plaid shirts and khaki pants to a
suit and tie. He works in a cubicle rather than a corner office.
Yet underneath the relaxed attitude lies his unwavering
support for the life sciences strategy he helped to pioneer.
Once seen as a visionary for his commitment to
developing the life sciences model that combines pharmaceuticals with
nutritional and agricultural products, analysts now question whether
Shapiro may have been too far ahead of his time as fierce opposition to
Monsanto's biotechnology spreads.
Shapiro joined Searle, Monsanto's pharmaceutical
business, in 1979 and also served as head of Monsanto's NutraSweet
artificial sweetener business and its agricultural unit before being named
chairman and chief executive in 1995.
With the Pharmacia merger, Shapiro would serve as
chairman but relinquish control of the day-to-day operations. He plans to
step down as chairman after 18 months, ending a career with Monsanto that
spanned two decades of rapid change in the pharmaceutical and agriculture
industries.
He is perhaps best-known for promoting the life sciences
model, a strategy that drew praise from analysts but has hurt Monsanto's
share price this year as opposition to genetically modified crops mounts
in Europe, Asia and to a lesser degree in the United States.
In fact, in a speech to Greenpeace in October, Shapiro
acknowledged that Monsanto appeared arrogant as it charged ahead with its
genetically modified crops without first assessing public opinion
and explaining the benefits.
Biotech foes contend there has not been enough research
to conclude that the crops are safe for the environment and for human
consumption. Last week, biotechnology opponents sued Monsanto, alleging it
rushed the genetically modified crops to market without first ensuring
they were safe.
Earlier this month, rivals Novartis AG and AstraZeneca
Plc. announced plans to break off and merge their agribusinesses, a move
analysts said may signal the end of the life sciences model.
Just two years ago, Shapiro was busy spending about $8
billion to buy genetically modified seed companies, turning Monsanto into
a leading producer of the technology.
The seed company purchases left Monsanto in need of
money, and it turned to cash-rich American Home Products Corp. as a merger
partner in 1998. The deal fell through later that year -- analysts blamed
the demise on differing management styles -- and Monsanto's stock price
tumbled from near $60 to the mid-$30s.
After the collapse of the American Home Products deal,
Monsanto remained at the forefront in promoting biotechnology, and Shapiro
gave several speeches touting the possibilities for improved farming
methods. After one such speech in San Francisco last year, Shapiro fell
victim to the pie-throwing environmental activists Biotic Baking Brigade,
which threw tofu creme and sweet potato pies at his face.
From there, opposition snowballed, and soon
biotechnology had made Monsanto a hated household name in Britain. The
genetically modified crops that Monsanto designed to improve crop yields
and help feed the world drew the fire of environmental activists, who
dubbed products made from the crops "Frankenfoods."
In a speech to Greenpeace in October, Shapiro himself
acknowledged that Monsanto inadvertently "irritated and antagonized
more people than we have persuaded" by pushing its vision of
biotechnology too quickly.
"Our confidence in this technology and our
enthusiasm for it has, I think, widely been seen -- and understandably so
-- as condescension or indeed arrogance," Shapiro said.
"Because we thought it was our job to persuade, too
often we forgot to listen," he said.
|